BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wolpaw AJ, Bayliss R, Büchel G, Dang CV, Eilers M, Gustafson WC, Hansen GH, Jura N, Knapp S, Lemmon MA, Levens D, Maris JM, Marmorstein R, Metallo SJ, Park JR, Penn LZ, Rape M, Roussel MF, Shokat KM, Tansey WP, Verba KA, Vos SM, Weiss WA, Wolf E, Mossé YP. Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers. Cancer Res 2021;81:1627-32. [PMID: 33509943 DOI: 10.1158/0008-5472.CAN-20-3108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Perri P, Ponzoni M, Corrias MV, Ceccherini I, Candiani S, Bachetti T. A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma. Cancers (Basel) 2021;13:5528. [PMID: 34771690 DOI: 10.3390/cancers13215528] [Reference Citation Analysis]
2 Whitfield JR, Soucek L. The long journey to bring a Myc inhibitor to the clinic. J Cell Biol 2021;220:e202103090. [PMID: 34160558 DOI: 10.1083/jcb.202103090] [Reference Citation Analysis]
3 Kling MJ, Griggs CN, McIntyre EM, Alexander G, Ray S, Challagundla KB, Joshi SS, Coulter DW, Chaturvedi NK. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma. BMC Cancer 2021;21:1061. [PMID: 34565342 DOI: 10.1186/s12885-021-08782-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Voeltzke K, Scharov K, Funk CM, Kahler A, Picard D, Hauffe L, Orth MF, Remke M, Esposito I, Kirchner T, Schramm A, Rotblat B, Grünewald TGP, Reifenberger G, Leprivier G. EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma. Cell Death Discov 2022;8:157. [PMID: 35379801 DOI: 10.1038/s41420-022-00963-0] [Reference Citation Analysis]
5 Spreafico F, Fernandez CV, Brok J, Nakata K, Vujanic G, Geller JI, Gessler M, Maschietto M, Behjati S, Polanco A, Paintsil V, Luna-Fineman S, Pritchard-Jones K. Wilms tumour. Nat Rev Dis Primers 2021;7:75. [PMID: 34650095 DOI: 10.1038/s41572-021-00308-8] [Reference Citation Analysis]